About Lumicell Diagnostics
Lumicell Diagnostics is a company based in Wellesley (United States) founded in 2008 by Moungi Bawendi and W David Lee. Lumicell Diagnostics has raised $360.8 million across 18 funding rounds from investors including HHS, LaunchCapital and BlueIO. The company has 23 employees as of December 31, 2023. Lumicell Diagnostics offers products and services including LumiSystem, LUMISIGHT, and Lumicell DVS. Lumicell Diagnostics operates in a competitive market with competitors including Averto Medical, On Target Laboratories, Huake Precision (Beijing) Medical Technology, C-RAD and US Medical Innovations, among others.
- Headquarter Wellesley, United States
- Employees 23 as on 31 Dec, 2023
- Founders Moungi Bawendi, W David Lee
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$360.8 M (USD)
in 18 rounds
-
Latest Funding Round
$198.13 M (USD), Series D
Apr 22, 2025
-
Investors
HHS
& 3 more
-
Employee Count
23
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lumicell Diagnostics
Lumicell Diagnostics offers a comprehensive portfolio of products and services, including LumiSystem, LUMISIGHT, and Lumicell DVS.
Real-time system for detecting residual breast cancer during lumpectomy.
Agent that illuminates cancer for intraoperative visualization.
Technology for real-time cancer excision guidance in surgery.
People of Lumicell Diagnostics
Unlock access to complete
Funding Insights of Lumicell Diagnostics
Lumicell Diagnostics has successfully raised a total of $360.8M across 18 strategic funding rounds. The most recent funding activity was a Series D round of $198.13 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lumicell Diagnostics
Lumicell Diagnostics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, LaunchCapital and BlueIO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm investing in seed & early stage companies in the US
|
Locked | Locked | Locked | |
|
Investments are made by BlueIO in early-stage technology companies.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Lumicell Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lumicell Diagnostics
Investment portfolio details for Lumicell Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lumicell Diagnostics
Detailed financials for Lumicell Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lumicell Diagnostics Comparisons
Peer comparison for Lumicell Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lumicell Diagnostics
Lumicell Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Averto Medical, On Target Laboratories, Huake Precision (Beijing) Medical Technology, C-RAD and US Medical Innovations, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical devices for gastrointestinal disease patients are developed.
|
|
| Locked | Locked | Locked |
Molecular imaging agents for cancer surgery are developed.
|
|
| Locked | Locked | Locked |
Neurosurgery robots are provided for neurological disorder treatments.
|
|
| Locked | Locked | Locked |
Oncology treatments are delivered through standalone clinics.
|
|
| Locked | Locked | Locked |
Electrosurgery and plasma technology for cancer treatment are developed.
|
Detailed competitors of Lumicell Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lumicell Diagnostics
Complete news archive for Lumicell Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lumicell Diagnostics
Lumicell Diagnostics was founded in 2008 and raised its 1st funding round 2 years after it was founded.
Lumicell Diagnostics is headquartered in Wellesley, United States. It is registered at Wellesley, Massachusetts, United States.
Howard Hechler is the current CEO of Lumicell Diagnostics.
Lumicell Diagnostics is a funded company, having raised a total of $360.8M across 18 funding rounds to date.
As of Dec 31, 2023, the latest employee count at Lumicell Diagnostics is 23.
Lumicell Diagnostics was established in 2008 in Wellesley, United States, within the medical imaging sector. Fluorescence-guided systems are created to support surgeons in visualizing residual cancer tissue in real time during operations. Single-cell detection capabilities are integrated, enabling evaluation of the tumor bed after initial resection. Operations focus on oncology applications, with potential to lower recurrence rates and limit needs for follow-up radiation or chemotherapy.
Lumicell Diagnostics's top competitors include Huake Precision (Beijing) Medical Technology, Averto Medical and On Target Laboratories.
Lumicell Diagnostics offers LumiSystem, LUMISIGHT, and Lumicell DVS.
Lumicell Diagnostics has 4 investors. Key investors include HHS, LaunchCapital, BlueIO, and National Science Foundation.